Target intelligence / Profile preview

Cellular membrane proteins and viral envelope proteins

Molecular classification
Membrane protein, Glycoprotein, Receptor, Ion channel, Transporter
01

Overview

Cellular membrane proteins and viral envelope proteins constitute a vast and diverse class of molecules that facilitate the interaction between host cells and viruses. Cellular membrane proteins, including receptors, transporters, and ion channels, are essential for maintaining cellular homeostasis and mediating signal transduction across the lipid bilayer (Nature Reviews Molecular Cell Biology, 2020). Viral envelope proteins are specialized glycoproteins embedded in the viral envelope that facilitate infection by recognizing specific host receptors and mediating the fusion of viral and cellular membranes (Journal of Virology, 2012). In clinical pharmacology, these proteins are critical targets for preventing infection; drugs like entry inhibitors and monoclonal antibodies are designed to block these specific interactions (Nature Reviews Drug Discovery, 2016). However, as a collective term, this does not refer to a single therapeutic target but rather a broad biological category encompassing thousands of distinct proteins across various viral families and host tissues.

Other names
Cell surface proteinsViral glycoproteinsHost-pathogen interface proteinsEnvelope glycoproteinsViral attachment proteins
02

Mechanism of action

Drugs targeting these proteins typically act by blocking viral attachment to host receptors, inhibiting the conformational changes required for membrane fusion, or neutralizing viral surface antigens to prevent cell entry.

03

Biological functions

Viral entryCell-cell signalingSignal transductionMolecular transportCell adhesionImmune recognition
04

Disease associations

InfectionCancerInflammationAutoimmune disease
05

Safety considerations

Rapid emergence of viral resistance (escape mutants)Off-target disruption of host cell signalingPotential for autoimmunity due to cross-reactivitySystemic immunogenicity of protein-based therapies
06

Interacting drugs

Maraviroc

5 more in the full profile.

07

Biomarkers

Viral load (RNA/DNA titer)CD4+ T-lymphocyte countSurface receptor expression (e.g., ACE2, CCR5 levels)Neutralizing antibody titersViral glycoprotein mutations

Beyond the preview

Go deeper on Cellular membrane proteins and viral envelope proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membrane proteins and viral envelope proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call